HK1199794A1 - Processes for the preparation of peripheral opioid antagonist compounds and intermediates thereto - Google Patents
Processes for the preparation of peripheral opioid antagonist compounds and intermediates thereto Download PDFInfo
- Publication number
- HK1199794A1 HK1199794A1 HK15100253.5A HK15100253A HK1199794A1 HK 1199794 A1 HK1199794 A1 HK 1199794A1 HK 15100253 A HK15100253 A HK 15100253A HK 1199794 A1 HK1199794 A1 HK 1199794A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- formula
- compound
- alkyl
- independently
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161508817P | 2011-07-18 | 2011-07-18 | |
| US61/508,817 | 2011-07-18 | ||
| PCT/US2012/047082 WO2013012871A1 (en) | 2011-07-18 | 2012-07-17 | Processes for the preparation of peripheral opioid antagonist compounds and intermediates thereto |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1199794A1 true HK1199794A1 (en) | 2015-07-24 |
Family
ID=47558430
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15100253.5A HK1199794A1 (en) | 2011-07-18 | 2012-07-17 | Processes for the preparation of peripheral opioid antagonist compounds and intermediates thereto |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20150045556A1 (enExample) |
| EP (1) | EP2734041A4 (enExample) |
| CN (1) | CN103917096A (enExample) |
| AU (1) | AU2012284127A1 (enExample) |
| CA (1) | CA2842183A1 (enExample) |
| HK (1) | HK1199794A1 (enExample) |
| IL (1) | IL230506A0 (enExample) |
| IN (1) | IN2014DN00137A (enExample) |
| WO (1) | WO2013012871A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103804431A (zh) * | 2014-02-25 | 2014-05-21 | 中国人民解放军第四军医大学 | 一种手性二茂铁双膦配体及其制备方法 |
| EP3421455B1 (en) * | 2017-06-29 | 2019-03-27 | F.I.S.- Fabbrica Italiana Sintetici S.p.A. | Improved process for the preparation of chiral 3-amino-piperidins, useful intermediates for the preparation of tofacitinib |
| WO2019028228A1 (en) | 2017-08-02 | 2019-02-07 | Vertex Pharmaceuticals Incorporated | PROCESSES FOR THE PREPARATION OF PYRROLIDINE COMPOUNDS |
| AU2018380426B2 (en) | 2017-12-08 | 2023-05-18 | Vertex Pharmaceuticals Incorporated | Processes for making modulators of cystic fibrosis transmembrane conductance regulator |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR245933A1 (es) * | 1987-04-16 | 1994-03-30 | Lilly Co Eli | Procedimiento para preparar compuestos de 4-(3-hidroxifenil)metil-3-alquil-n-alquilpiperidina y sus sales. |
| US5536858A (en) * | 1994-02-12 | 1996-07-16 | Hoffmann-La Roche Inc. | Tetrasulfonated diphosphine compounds and metal complexes thereof for asymmetric catalytic reactions |
| US5553858A (en) * | 1995-06-28 | 1996-09-10 | Mckoon; Carl T. | Golf putter |
| US6057456A (en) * | 1997-10-16 | 2000-05-02 | Yale University | Transition metal-catalyzed process for preparing alpha-arylated carbonyl-containing compounds |
| US6900228B1 (en) * | 1998-03-10 | 2005-05-31 | Research Triangle Institute | Opiate compounds, methods of making and methods of use |
| TWI254043B (en) * | 1999-06-08 | 2006-05-01 | Hoffmann La Roche | Ethanesulfonyl-piperidine derivatives having good affinity to N-methyl-D-aspartate (NMDA) receptor |
| US6794510B2 (en) * | 2002-08-08 | 2004-09-21 | Adolor Corporation | Processes for the preparation of peripheral opioid antagonist compounds and intermediates thereto |
| CN102245562B (zh) * | 2008-12-18 | 2014-08-13 | 弗·哈夫曼-拉罗切有限公司 | 合成氨基-甲基四氢化萘衍生物的方法 |
-
2012
- 2012-07-17 EP EP12814994.5A patent/EP2734041A4/en not_active Withdrawn
- 2012-07-17 US US14/233,670 patent/US20150045556A1/en not_active Abandoned
- 2012-07-17 HK HK15100253.5A patent/HK1199794A1/xx unknown
- 2012-07-17 IN IN137DEN2014 patent/IN2014DN00137A/en unknown
- 2012-07-17 CA CA2842183A patent/CA2842183A1/en not_active Withdrawn
- 2012-07-17 CN CN201280045401.8A patent/CN103917096A/zh active Pending
- 2012-07-17 WO PCT/US2012/047082 patent/WO2013012871A1/en not_active Ceased
- 2012-07-17 AU AU2012284127A patent/AU2012284127A1/en not_active Abandoned
-
2014
- 2014-01-16 IL IL230506A patent/IL230506A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2012284127A1 (en) | 2013-05-02 |
| CN103917096A (zh) | 2014-07-09 |
| IL230506A0 (en) | 2014-03-31 |
| EP2734041A4 (en) | 2015-03-25 |
| US20150045556A1 (en) | 2015-02-12 |
| CA2842183A1 (en) | 2013-01-24 |
| IN2014DN00137A (enExample) | 2015-05-22 |
| WO2013012871A1 (en) | 2013-01-24 |
| EP2734041A1 (en) | 2014-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102899506B1 (ko) | 치환된 헤테로사이클 융합 감마-카르볼린 합성 | |
| WO2009064476A1 (en) | Preparation of sitagliptin intermediate | |
| EP3297678B1 (en) | An improved processes for the preparation of carfilzomib or pharmaceutically acceptable salts thereof | |
| WO2014059938A1 (zh) | 一种利拉列汀重要中间体的制备方法 | |
| US6794510B2 (en) | Processes for the preparation of peripheral opioid antagonist compounds and intermediates thereto | |
| JP7685292B2 (ja) | エドキサバンの鍵中間体及びその合成方法 | |
| HK1199794A1 (en) | Processes for the preparation of peripheral opioid antagonist compounds and intermediates thereto | |
| JP2007519710A (ja) | １−（２Ｓ，３Ｓ）−２−ベンズヒドリル−Ｎ−（５−ｔｅｒｔ−ブチル−２−メトキシベンジル）キヌクリジン−３−アミンの製造方法 | |
| EP2285799A2 (en) | Method for preparing argatroban monohydrate | |
| JP6947354B2 (ja) | リナグリプチンの製造法 | |
| US8927742B2 (en) | Process for preparing Nebivolol | |
| WO2016039393A1 (ja) | アミノ酸誘導体の製造方法 | |
| EP2922833A1 (en) | Process for the preparation of (1s,4s,5s)-4-bromo-6-oxabicyclo[3.2.1]octan-7-one | |
| WO2018041873A1 (en) | Process for the preparation of (6s)-6-isopropyl-10-methoxy-9-(3-methoxypropoxy)-2-oxo-6,7-dihydrobenzo[a]quinolizine-3-carboxylic acid | |
| WO2010053944A1 (en) | Improved method of making piperidine derivatives | |
| US20080214837A1 (en) | Synthetic Method of Optically Pure (S)-3-Hydroxypyrrolidine | |
| CN103755624B (zh) | 一种哌啶衍生物的合成方法 | |
| WO2015109377A1 (en) | Process for preparing donepezil hydrochloride forms i and iii; and an intermediate compound thereof | |
| KR102184129B1 (ko) | 의약품 합성용 중간체 화합물의 제조 방법 | |
| CN117263850A (zh) | 一种雷芬那辛的合成方法 | |
| AU2024323952A1 (en) | Process for the preparation of preparing 1-ethyl-n-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)piperidine-4-sulfonamide | |
| CN101001854A (zh) | 高选择性的新型酰胺化方法 | |
| KR100896087B1 (ko) | 광학적으로 순수한 2-메틸피롤리딘 및 그 염의 제조방법 | |
| JP2018525366A (ja) | イブルチニブの製法及び新規な合成中間体 | |
| HK1200818A1 (en) | (3,4-dichloro-phenyl)-((s)-3-propyl-pyrrolidin-3-yl)-methanone hydrochloride and manufacturing processes |